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The ability of fd bacteriophage particles to trigger diﬀerent arms of the immune system has been previously shown by us with
particular emphasis on the ability of phages to raise CTL responses in vitro and in vivo. Here we show that fd virions in the
absence of adjuvants are able to evoke a DTH reaction mediated by antigen speciﬁc CD8+ T cells. In addition, we analyzed the
induction of CTL responses in mice depleted of CD4+ T cells, and we observed that short-term secondary CTL responses were
inducedintheabsenceofCD4+Tcellswhileinductionoflong-termmemoryCTLsrequiredthepresenceofCD4+Tlymphocytes.
These results examine the cellular mechanism at the basis of fd eﬃciency and provide new elements to further validate the use of
fd particles for eliciting and monitoring antigen-speciﬁc CTLs.
1.Introduction
The system of antigen delivery by bacteriophage is based
on the modiﬁcation of the phage display technology. The
ﬁlamentous bacteriophage fd is well understood at both
the structural and genetic levels [1]. The capsid contains
one major protein pVIII largely alpha helical which forms
a shingled tubular array surrounding the single-stranded
viral DNA with its N-terminal regions exposed on the viral
surface. Given the large number of pVIII proteins (approx-
imately 2700 copies per virion), the peptides displayed on
pVIII, evenif expressed in alower copy number onthe phage
particles,remaindenselyrepresented.Thereisgoodevidence
fromimmunoassaysandNMRspectroscopythattheexposed
peptides adopt a stable three-dimensional structure closely
resembling that which they exhibit in the wild-type parent
proteins[2].Theunexpectedobservationthatfdﬁlamentous
bacteriophage particles are taken up and processed by the
major histocompatibility (MHC) class I pathway [3]a n d
a r ea b l et ot r i g g e rc y t o t o x i cTl y m p h o c y t e s( C T L s )[ 4, 5],
suggested that fd virions represent an eﬃcient system for
antigen delivery. Here we investigate the use of fd virions
that display an epitope recognized by CD8+ T cells to
mediate a delayed type hypersensitivity (DTH) reaction,
demonstrating the ability of fd bacteriophages to elicit DTH
in the absence of adjuvants.
In addition, we analyze the cell subsets involved in the
induction of secondary memory CTL responses. Since it
is known that coexpression of linked helper T cell and
cytotoxic T cell epitopes on the surface of the same antigen-
presenting cell (APC) is a requirement for priming a CTL
response, initially we designed hybrid bacteriophages that
simultaneously display helper and cytotoxic epitopes on
the same virion. Using these double-display bacteriophage
particles we showed that bacteriophage virions are able to
elicit a sustained and antigen-speciﬁc CTL response both
in vitro and in vivo [4, 5]. However, in further studies we
also observed that single hybrid phages displaying a strong
CTL epitope (OVA257–264)w e r ea b l et oi n d u c ea ne ﬃcient
CTL response even in the absence of a T helper exogenous
epitope [6]. We hypothesized that the carrier fd may also
containH-2restrictedCD4+Thelperepitopesandthatthese2 Journal of Biomedicine and Biotechnology
latter may exert a suﬃcient helper function in C57BL/6 mice
when strong CTL epitopes, such as OVA257–264, are displayed
on fd bacteriophages. To better address this issue here we
analyze the CTL induction by single-display fd virions in
mice depleted of CD4+ T cells.
2.MaterialsandMethods
2.1. Construction and Puriﬁcation of Hybrid Bacteriophages.
Single hybrid bacteriophages fdOVA257–264 were generated
by cloning the DNA fragment encoding the OVA257–264
(SIINFEKL) MHC H-2b-restricted cytotoxic peptide
(5 -CCGCGGAGGGTTCCATCATCAACTTCGAAAAAC-
TGGACGATCCCGCCAAGG-3 ) into SacII-StyI-digested
fdAMPLAY88 phage genome as previously described
[6]. E. coli XL1-Blue MRF’ Kan cells, transformed with
recombinant bacteriophages, produced hybrid phages in
the supernatant. The wild type (fdwt) or recombinant
virions were harvested from the bacteria culture medium,
puriﬁed by caesium chloride gradient, and analyzed by
SDS-PAGE as described elsewhere [7]. The number of copies
of pVIII displaying OVA257–264 peptide was determined by
N-terminal sequence analysis for each phage preparation,
and the concentration of the antigenic peptide on the
fdOVA257–264 bacteriophages was calculated from the copy
number of the modiﬁed pVIII in the hybrid virions. The
single hybrid phage preparations (fdOVA257–264), carrying
the OVA257–264 peptide, displayed 450–750 recombinant
copies of major coat protein pVIII [6].
2.2. Delayed Type Hypersensitivity Test (DTH). At o t a lo f
35 mice were sensitized by one injection of 50μg of the
cytotoxic OVA257–264 (SIINFEKL) peptide and 140μgo f
the T helper HBVc128–140 (TPPAYRPPNAPIL) peptide from
hepatitis B virus core antigen, emulsiﬁed with incomplete
Freund’s adjuvant (Sigma, Milan, Italy). Eight-week-old
female C57BL/6 mice were purchased from Harlan Nossan
(Corezzana, Italy) and maintained at the IGB animal facility,
according to the Institutional guidelines. Sentinel mice were
screened for seropositivity to Sendai virus, Rodent Coron-
avirus, and Mycoplasma pulmonis by the Murine Immuno-
comb test (Charles River, Lecco, Italy) and were found to
be negative. All experiments with mice were performed in
accordance with European Union Laws and guidelines. All
animal studies were approved by our institutional review
board, and the animal procedures (i.e., immunization and
sacriﬁce) were performed according to rules approved by the
ethical committee.
Peptides were purchased from Primm (Milan, Italy).
Purity was >95%, as analyzed by HPLC and mass spectrom-
etry. Ten days after sensitization, DTH was performed by
injecting the antigen into the right footpad and PBS into
the left footpad. Between 10 and 48 hours later the area
of swelling was measured using a caliper. DTH reactions
were elicited in mice after injection of, respectively, 75μg
fdOVA257–264 (displaying 2μgo fO V A 257–264 peptide), 75μg
of fdwt, 2μgo fO V A 257–264 synthetic peptide, 75μgo ff d w t
plus 2μgo fO V A 257–264 synthetic peptide, or 100μgo fp u r e
soluble ovalbumin (Sigma, Milan, Italy).
2.3. In Vivo CD4+ Depletion and Mice Immunization. The
rat antimouse CD4 mAb GK1.5 (IgG2b) was puriﬁed
from hybridoma GK1.5 (ATCC TIB-207, Manassas, VA,
USA) culture supernatant by aﬃnity chromatography on
HiTrap Protein-G column (Amersham-Pharmacia, Freiburg,
Germany). Treatment with the depleting anti-CD4 mAb
GK1.5 was performed i.p. as previously described [8]o n
days −3, 1, 3, and every 3 days until the boost, with
200μg of anti-CD4 mAb. After boost, for assaying long-term
responses, the treatment with anti-CD4 mAb was repeated
on a weekly basis. Noncompeting FITC-conjugated anti-
CD4 mAb (clone RM4-4; BD Pharmingen, Milan, Italy)
was used for in vivo CD4+ T cell depletion assessment.
The eﬃciency of CD4+ T cell depletion was controlled by
FACS analysis (FACSAria, Becton Dickinson) on spleen cells
isolated from representative mice sacriﬁced at various time
points.
The immunizations were performed on days 0 and
15 using 50μg fdOVA257–264 administered either subcu-
taneously without adjuvant, or intraperitoneally in the
presence of poly I:C, according to the following protocol:
group a: 50μg fdOVA257–264;g r o u pb :5 0μg fdOVA257–264
plus anti-CD4 mAb; group c: 50μg fdOVA257–264 plus 10μg
o fp o l yI : Ca d j u v a n t ;gr o u pd :u n tr e a t e dm i c e .T h em i c ew e r e
sacriﬁced 2 weeks after the boost or two months later.
2.4. Cytotoxicity Assay. Single splenocyte suspensions were
prepared by mechanical disruption from either control or
immunized mice (responder cells) and were tested for anti-
OVA257–264 peptide cytotoxic response by the JAM Test
[9]. Brieﬂy, responder cells (4 × 106 cells per well) were
stimulated in 24-well plates with irradiated syngenic female
spleen cells (stimulator cells, 2 × 106 per well), which
were prepulsed with OVA257–264 peptide at 10μg/mL, in
the presence of IL-2 at 20U/mL. As a positive control,
spleen cells from each mouse were stimulated in parallel
cultures with irradiated BALB/c female spleen cells, bearing
the H-2d alloantigen (antiallo response). After 6-7 days cells
were harvested and tested for cytotoxic activity against 3H-
TdR labelled targets in a 4-hour assay. The anti-OVA257–264
peptide responder cells were tested against EL4 target cells
(H-2b, syngenic to C57BL/6 mice) which had been either
prepulsed or not with OVA257–264 peptide; the anti-allo
responder cells were tested against either P815 (H-2d)o rE L 4
target cells.
2.5. Elispot Assay. The responder cells were prepared as
above from either control or immunized mice. Cells were
incubated in anti-IFN-γ mAb precoated multiscreen plates
with IL-2 at 20U/mL and 5 × 105 irradiated syngenic
spleen cells, prepulsed with either OVA257–264 at 10μg/mL
or medium alone. Responder cells (5 × 105/well) from each
mouse were incubated with either medium alone or ConA
at 10ng/mL. After 40 hours of incubation at 37
◦C, cells
were washed and the plates were sequentially incubated
with anti-IFN-γ biotinylated mAb, poly-HRP-streptavidin
(Endogen, Woburn, MA, USA), and AEC substrate (Sigma,
Milan, Italy). IFN-γ transfected TSA cells and the parentalJournal of Biomedicine and Biotechnology 3
untransfected line were used as controls in each ELISPOT
plate, after gamma irradiation. The spots were counted using
the ELISPOT reader (A.EL.VIS, Hannover, Germany).
2.6. Statistical Analysis. All statistical analyses were per-
formed using the unpaired Student’s t-test. Diﬀerences were
considered statistically signiﬁcant when P<. 01.
3. Results
3.1. Use of Single Hybrid Phage fdOVA257–264 to Evoke a
Delayed Type Hypersensitivity Reaction (DTH). In order to
verify if the fd bacteriophages could be used as a vehicle to
monitor the presence of antigen-speciﬁc CD8+ T cells, we
set up an experimental model to reproduce a prior exposure
to the antigen. We sensitized C57BL/6 mice injecting them
at the base of the tail, with a mixture of OVA257–264
cytotoxic peptide, HBVc helper peptide, and incomplete
Freund’s adjuvant. In this model the development of DTH
normallytakes 10 days from the time of immunization. DTH
reaction was generated injecting 10 mice with recombinant
fdOVA257–264, 10 mice with wild type fd ﬁlamentous bacte-
riophages (fdwt), ﬁve mice with OVA257–264 peptide, and ﬁve
mice with soluble ovalbumin into the right footpad. The left
footpad was instead treated with the same volume of PBS.
Figure 1(a) shows the measurements of footpad swelling
(mean ± SD) at diﬀerent time points in response to the DTH
skin test (value of PBS background was subtracted for each
point).
A signiﬁcant swelling between 24 and 48 hours was
inducedinthefootpadofmicechallengedwithfdOVA257–264
virions. In contrast a DTH reaction was not observed in
mice challenged with wild type phage, synthetic OVA257–264
peptide or soluble ovalbumin. These results indicate that
DTH reaction is triggered by fd virions displaying the
OVA257–264 epitope and that DTH is thus induced by
OVA257–264-speciﬁc CD8+ T cells.
Figure 1(b)summarizesthemean ±increaseofthickness
for each mice group at 30 hours. The mice injected with
fdOVA257–264 show a mean of 0.65mm of footpad swelling
compared with 0.15mm of footpad swelling of mice injected
with fdwt. The groups challenged with the synthetic peptide
or with soluble ovalbumin do not show signiﬁcant swelling,
meaning that these are not eﬀective in eliciting the DTH
reaction, while, as mentioned above, DTH was induced by
administration of fdOVA257–264 in the absence of adjuvant.
Statistical analysis (Student’s t-test) revealed that diﬀerences
between DTH induced by fdOVA257–264 with respect to
DTH induced with other challenges were signiﬁcant (P<
.01, Figure 1(b)). The use of synthetic OVA257–264 peptide
in the presence of fdwt did not elicit DTH (data not
shown). This indicates that DTH was conferred by the
antigenic determinant displayed on the phage surface and
that induction of DTH by fdOVA257–264 virions could not be
ascribed to the presence of LPS contaminants in the phage
preparations, since the same amount of LPS was present in
fdOVA257–264 and fdwt samples.
3.2. Use of Single Hybrid Phage FdOVA257–264 to Induce
CTL Response in Mice Depleted of CD4+ T Cells. Our
goal was to determine whether responses to single hybrid
bacteriophages carrying a CTL epitope (fdOVA257–264)c o u l d
be generated and maintained in the absence of CD4+
T cells. We administered fdOVA257–264 without adjuvant
to mice depleted of CD4+ T lymphocytes by anti-CD4
antibody treatment [8] and then measured the secondary
cytotoxic response. Speciﬁcally, we immunized groups of
C57BL/6 mice according to the following protocol: (a) 50μg
fdOVA257–264;( b )5 0 μg fdOVA257–264 plus anti-CD4; (c)
50μg fdOVA257–264 plus poly I:C. Untreated mice were used
as control.
Figure 2 summarizes the results obtained with all groups
of mice. Figure 2(a) shows the percentage of speciﬁc lysis
after subtraction of background lysis of unpulsed target, at
the responder/target ratio 270 : 1, while Figure 2(b) shows
the ELISPOT assay to measure the frequency of IFN-γ
producing splenocytes in response to in vitro stimulation
with OVA257–264 synthetic peptide. The results indicate
that the ﬁlamentous bacteriophages administered without
adjuvant are able to induce both relevant antigen-speciﬁc
CTLs (mean 29.6% of lysis) and INFγ production (mean
124 Spot Forming Cells (SFC)/million cells) although these
responses were lower than those obtained with fdOVA257–264
administered in the presence of poly I:C adjuvant (37% lysis
and 189 SFC/million cells). When we depleted the CD4+
T lymphocytes, the lytic activity and the IFN-γ production
of antigen-speciﬁc CD8+ T cells were lower (17% of lytic
activity and 94 SFC INFγ/million cells) than those obtained
in the presence of CD4+ T cells, but these diﬀerences were
notstatisticallysigniﬁcant(P>. 05).ThepresenceofCTLsin
CD4+ T cell depleted mice indicates a secondary expansion,
since a single administration of fdOVA257–264 particles was
not suﬃcient to induce CTL activity (data not shown).
A group of mice was also immunized with 50μgo f
fdOVA257–264 without adjuvant and treated with anti-CD4
mAb for two months after boost in order to establish if
CD4+ T lymphocytes were necessary for inducing long-term
memorycellresponse.AsillustratedinFigures2(c)and2(d),
we observed no antigen-speciﬁc immune response by either
cytotoxic test or ELISPOT assay in these mice, in contrast to
long-term responses of positive controls. Statistical analysis
conﬁrmed signiﬁcant diﬀerences between fdOVA257–264 and
fdOVA257–264 + anti-CD4 mice groups either for the lytic
activity (P = .0004) or the IFNγ production (P = .0002).
The eﬃciency of CD4+ T cells depletion was controlled
by FACS analysis of spleen cells isolated from mice treated
with anti-CD4 antibodies at diﬀerent time points: before
treatment;dayofﬁrstimmunization;dayofboost;twoweeks
after boost (short-term memory); two months later (long-
term memory). The data illustrated in Figure 2(e) show
>99% CD4+ T cell depletion in mice treated with anti-
CD4 mAb, in agreement with data previously reported in
[8]. The percentage of CD8+ spleen cells was similar in
mice CD4-depleted and not depleted (data not shown).
In conclusion, short-term secondary response following
fdOVA257–264 immunization is independent from T cell help
but long-term secondary response is T helper dependent and4 Journal of Biomedicine and Biotechnology
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Figure 1: fdOVA257–264 administration is able to trigger DTH. Mice were sensitized by one injection of 50μg of cytotoxic OVA257–264
(SIINFEKL) peptide and 140μg T helper HBVc128–140 (TPPAYRPPNAPIL) peptide from hepatitis B virus core antigen, emulsiﬁed with
incomplete Freund’s adjuvant. Ten days after sensitization, DTH was performed by injecting into the right footpad fdOVA257–264,f d w t ,t h e
synthetic OVA257–264 peptide (pepOVA), or soluble ovalbumin. 10–48 hours later the area of swelling was measured using a caliper. (a) Curve
response of all mice analyzed. (b) Values at 30 hours of mean thickness ± SD of the diﬀerent mice groups challenged with the antigens
indicated in the abscissa. The P-values were calculated by comparing each group with the fdOVA257–264 challenged group.
was not observed following fdOVA257–264 immunization in
mice depleted of CD4+ T lymphocytes.
4. Discussion
Cellular immunity, particularly cytotoxic T lymphocyte
activity, plays a role in the clearance of viral infections and
in the control of tumor development. Therefore induction
of CTL activity is a major goal of vaccine development and
its achievement may be determined by the ability of a carrier
to deliver antigens into the MHC class I pathway. Here we
report a study on the use of fd ﬁlamentous bacteriophage
as an eﬃcient carrier for delivering CTL epitopes. The
bacteriophage fd is a nonpathogenic virus that is not able to
infect and replicate in eukaryotic cells. All available evidence
indicates that bacteriophage administration is completely
harmless to humans [10–12]. In the past few years we
have shown that fd bacteriophage particles represent a good
antigen delivery system both for T helper and CTL epitopes
since these particles intersect both class I and class II
pathways [3–5].
In this paper we show that fd particles can also be
used to induce DTH reaction, and this may allow the in
vivo monitoring of immune responses mediated by antigen-
speciﬁc CD8+ T cells. In a previously reported study [13], fd
virions were used to sensitize mice and then to induce DTH
reaction. Here we used fd virions only to challenge the DTH
in mice sensitized by the administration of a combination
of synthetic helper and CTL peptides. Thus we proved
that fd bacteriophages are able to stimulate in the tissue
the OVA257–264 speciﬁc CD8+ T lymphocytes which were
primed by a diﬀerent delivery of the OVA257–264 antigenic
determinant. DTH reactions in the skin have been observed
in many immunotherapy protocols and are often used as an
indicator of antitumor immunity and virus vaccine eﬃcacy
[14, 15]. In addition, since DTH is relatively straightforward
to perform, it may be employed as a preliminary screen
for diagnostic virus infection and may serve as an in vivo
measure of the lymphocytes traﬃcking to sites of infection
[16].
Here we also analyze the role of CD4+ T cells in the
induction by fd virions of CTL memory responses. We
previously described that the display of the CTL epitope
OVA257–264 (SIINFEKL) on the surface of fd virions is
suﬃcient to sustain an MHC class I restricted cytotoxic T
lymphocyte response in vivo [6]. Having assessed the in
vivo cross-presentation of the OVA257–264 epitope displayed
on bacteriophages, our aim was to investigate the cellular
mechanismthatthiscarrieremploystostimulateCTLinduc-
tion. The importance of speciﬁc CD4+ T cell help for CD8+
T cell mediated immunity is known; however interactions
between cross presenting DC, CD4+ T cells and CD8+ T
cells in the establishment of immunological memory are
still not well deﬁned. A previous study conﬁrmed that T
helper cells are required for secondary induction of CTLs
in vitro and in vivo, since CD4+ T cell depletion caused
the complete disappearance of antigen-speciﬁc CTLs after
secondary stimulation [17].
In this context our ﬁnding is of interest. In fact, we
determined that fd particles carrying the OVA257–264 peptideJournal of Biomedicine and Biotechnology 5
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Figure 2: CTL and IFN-γ responses in mice immunized with fd bacteriophage particles in the presence or in the absence of CD4+ T cell
help. Mice were immunized by two injections with either fdOVA257–264 plus poly I:C or fdOVA257–264 particles as indicated in Materials and
Methods. Immunizations with fdOVA257–264 particles were also performed in mice depleted of CD4+ T cells by treatment with GK1.5mAb.
CTL and IFN-γ productions were assayed after 15 days (a, b) or after two months (c, d) from the last injection. Each symbol represents data
obtained from a single mouse. The mean value ± SD for each group is reported. (e) CD4+ T cell depletion was analyzed by cytoﬂuorometry
using noncompeting anti-CD4 antibody. The analysis was performed on spleen cells isolated from mice sacriﬁced at the time points
indicated.
are still able to induce secondary expansion of OVA257–264-
speciﬁc CTLs even in the absence of CD4+ T cells. It has
been suggested that an alternatively CD4+ Th-independent
pathway of CTLs activation may operate via recognition
of molecular pattern recognition receptors (PRRs) by DC
[18] that in turn initiate signaling cascades activating the
DC to provide T cell costimulation and cytokine release. In
particular,ithasbeenreportedthatsmallamountofIL-2can
be produced also by DC [19], and the addition of exogenous
IL-2 to mice depleted of CD4+ T cells restores the secondary
expansion of CTL [17]. We plan to investigate in future work
the ability of phages to function as PRR agonist, to induce
cytokine production, maturation of DCs, and to upregulate
their costimolatory molecules.
ThisstudyreportsthatwhilethepresenceofCD4+Tcells
isnotessentialtoinduceasecondarymemoryresponse,their
presence is instead required to elicit a long-term memory
response by fd antigen delivery. This ﬁnding should be6 Journal of Biomedicine and Biotechnology
taken into consideration in designing fd particles for vaccine
strategies.
5. Conclusions
Overall our analysis of the cellular mechanisms employed by
fd virions contributes toward deﬁning the potentiality of this
safe and inexpensive antigen delivery system, which has been
proposed as a subunit vaccine able to improve the antigenic-
ity and the immunogenicity of the antigenic determinants
displayed. We show that the fd particles displaying a CTL
epitope, and not the synthetic peptide, can be used without
adjuvants to activate the antigen-speciﬁc CD8+ T cells in the
tissue, and to evoke a DTH reaction. This result suggests that
f db a c t e r i o p h a g e sc a nb eu s e da sad i a g n o s t i ct o o lt oi nv i v o
monitor both infections and the presence of antigen-speciﬁc
CD8+ T cells. Moreover, since the fd system can be applied
to vaccine formulation, we have deﬁned the role of CD4+
T cells in the induction of long-term memory responses. We
foundthatthepresenceofCD4+Tcellsisrequiredtosustain
long-terminductionofCTLs.Inthiscontext,inthefdsystem
coactivation of CD4+ T cells can easily be achieved for all
types of MHC-restricted antigens by constructing double
hybrid bacteriophages displaying helper and CTL epitopes
on the same virion.
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